XML 56 R31.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Schedule 1-Condensed Financial Information of Registrant Orthofix International N.V. | 12 Months Ended
--- | ---
Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
Schedule 1-Condensed Financial Information of Registrant Orthofix International N.V. | Schedule 1—Condensed Financial Information of Registrant Orthofix International N.V. Condensed Balance Sheets (unaudited)
(U.S. Dollars in thousands) |  | December 31, 2013 |  |  | December 31, 2012 |
|  | (Restated) |  |  | (Restated) |
Assets |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 1,426 |  |  | $ | 7,392 |
Prepaid expenses and other current assets |  |  | 670 |  |  |  | 534 |
Total current assets |  |  | 2,096 |  |  |  | 7,926 |
Other long term assets |  |  | — |  |  |  | 15 |
Investments in and amounts due from subsidiaries and affiliates |  |  | 308,173 |  |  |  | 357,811 |
Total assets |  | $ | 310,269 |  |  | $ | 365,752 |
Liabilities and shareholder’s equity |  |  |  |  |  |  |  |
Current liabilities |  | $ | 6,295 |  |  | $ | 1,202 |
Long-term liabilities |  |  | 8,111 |  |  |  | 8,111 |
Shareholder’s equity: |  |  |  |  |  |  |  |
Common stock |  |  | 1,810 |  |  |  | 1,934 |
Additional paid in capital |  |  | 216,653 |  |  |  | 246,306 |
Accumulated earnings |  |  | 73,897 |  |  |  | 102,709 |
Accumulated other comprehensive income |  |  | 3,503 |  |  |  | 5,490 |
|  |  | 295,863 |  |  |  | 356,439 |
Total liabilities and shareholder’s equity |  | $ | 310,269 |  |  | $ | 365,752 |
See accompanying notes to condensed financial statements. Orthofix International N.V. Schedule 1—Condensed Financial Information of Registrant Orthofix International N.V. Condensed Statements of Operations (unaudited)
(U.S. Dollars in thousands) |  | Year Ended December 31, 2013 |  |  | Year Ended December 31, 2012 |  |  | Year Ended December 31, 2011 |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
(Expenses) income: |  |  |  |  |  |  |  |  |  |  |  |
General and administrative |  | $ | (16,641 | ) |  | $ | (7,700 | ) |  | $ | (11,134 | )
Equity in earnings of investments in subsidiaries and affiliates |  |  | (12,494 | ) |  |  | 50,331 |  |  |  | (5,884 | )
Other, net |  |  | 323 |  |  |  | 24 |  |  |  | 7 |
(Loss) income before income taxes |  |  | (28,812 | ) |  |  | 42,655 |  |  |  | (17,011 | )
Income tax benefit (expense) |  |  | — |  |  |  | 197 |  |  |  | (687 | )
Net (loss) income |  | $ | (28,812 | ) |  | $ | 42,852 |  |  | $ | (17,698 | )
See accompanying notes to condensed financial statements. Orthofix International N.V. Schedule 1—Condensed Financial Information of Registrant Orthofix International N.V. Condensed Statement of Cash Flows (unaudited)
(U.S. Dollars in thousands) |  | Year Ended December 31, 2013 |  |  | Year Ended December 31, 2012 |  |  | Year Ended December 31, 2011 |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
Net (loss) income |  | $ | (28,812 | ) |  | $ | 42,852 |  |  | $ | (17,698 | )
Equity in earnings of (loss) investments in subsidiaries and affiliates |  |  | 12,494 |  |  |  | (50,331 | ) |  |  | 5,884 |
Cash (used in) provided by other operating activities |  |  | 468 |  |  |  | (6,811 | ) |  |  | 3,429 |
Net cash used in operating activities |  |  | (15,850 | ) |  |  | (14,290 | ) |  |  | (8,385 | )
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |
Distributions and amounts received from subsidiaries |  |  | 53,389 |  |  |  | 12,564 |  |  |  | 5,875 |
Capital expenditures |  |  | — |  |  |  | — |  |  |  | — |
Net cash provided by investing activities |  |  | 53,389 |  |  |  | 12,564 |  |  |  | 5,875 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from issuance of common stock |  |  | 3,450 |  |  |  | 25,586 |  |  |  | 20,113 |
Repurchase of treasury shares |  |  | (39,494 | ) |  |  | — |  |  |  | — |
Contributions to subsidiaries and affiliates |  |  | (7,543 | ) |  |  | (36,921 | ) |  |  | (2,789 | )
Tax benefit on exercise of stock options |  |  | 82 |  |  |  | 1,020 |  |  |  | 1,737 |
Net cash (used in) provided by financing activities |  |  | (43,505 | ) |  |  | (10,315 | ) |  |  | 19,061 |
Net (decrease) increase in cash and cash equivalents |  |  | (5,966 | ) |  |  | (12,041 | ) |  |  | 16,551 |
Cash and cash equivalents at the beginning of the year |  |  | 7,392 |  |  |  | 19,433 |  |  |  | 2,882 |
Cash and cash equivalents at the end of the year |  | $ | 1,426 |  |  | $ | 7,392 |  |  | $ | 19,433 |
See accompanying notes to condensed financial statements. Orthofix International N.V. Schedule 1—Condensed Financial Information of Registrant Orthofix International N.V. Notes to Condensed Financial Statements (unaudited)
1. | Background and basis of presentation
These condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule 1 of Regulation S-X, as the restricted net assets of Orthofix Holdings, Inc. and its subsidiaries exceed 25% of the consolidated net assets of Orthofix International N.V. and its subsidiaries (the “Company”). This information should be read in conjunction with the Company’s consolidated financial statements included elsewhere in this filing.
2. | Restricted net assets of subsidiaries
Certain of the Company’s subsidiaries have restrictions on their ability to pay dividends or make intercompany loans and advances pursuant to their financing arrangements. The amount of restricted net assets the Company’s subsidiaries held at December 31, 2013 and 2012 was approximately $168.5 million and $194.5 million, respectively. Such restrictions are on net assets of Orthofix Holdings, Inc. and its subsidiaries.
3. | Commitments, contingencies and long-term obligations
For a discussion of the Company’s commitments, contingencies and long term obligations under its senior secured credit facility, see Note 9, Note 12 and Note 17 of the Company’s consolidated financial statements.
4. | Dividends from subsidiaries
Orthofix International N.V. did not receive cash dividends in 2013 or 2012.

X
- Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 06 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7656940&loc=d3e5283-111683 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 12 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph c -Article 5 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph c -Article 7 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration